Literature DB >> 11331688

Cardiovascular effects of hydrocortisone in preterm infants with pressor-resistant hypotension.

I Seri1, R Tan, J Evans.   

Abstract

OBJECTIVE: To study the cardiovascular effects of hydrocortisone in preterm infants with hypotension unresponsive to volume and pressor administration. STUDY
DESIGN: Retrospective review of the cardiovascular response to 23 courses of hydrocortisone administration during the first day of treatment in 21 preterm infants (gestational age: 26.9 +/- 3.9 weeks; postnatal age: 11.3 +/- 13.1 days). Hydrocortisone (2 mg/kg/d in 16 patients and 3-6 mg/kg/d in 5 patients) was administered when dopamine (22.2 +/- 11 microg/kg/min, range: 8-60) alone (n = 16) or in combination with dobutamine (8.4 +/- 4.9 microg/kg/min, range: 5-20, n = 7) and/or epinephrine (0.38 +/- 0.56 microg/kg/min, range: 0.01-1.2, n = 4) failed to normalize blood pressure.
RESULTS: Mean blood pressure increased from 29.3 +/- 4.1 to 34.1 +/- 5.2, 38.0 +/- 8.0, and 41.8 +/- 6.6 mm Hg by 2, 4, and 6 hours of hydrocortisone administration, respectively, and remained stable thereafter. Urine output increased despite a decrease in fluid administration during the first day of hydrocortisone treatment. The dose of dopamine and the number of patients receiving dobutamine and/or epinephrine also decreased during the same period. Eighteen of the 21 patients survived.
CONCLUSIONS: Preterm infants with volume- and pressor-resistant hypotension respond to hydrocortisone with rapid normalization of the cardiovascular status and sustained decreases in volume and pressor requirement.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11331688     DOI: 10.1542/peds.107.5.1070

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  25 in total

Review 1.  Corticosteroids for treating hypotension in preterm infants.

Authors:  Hafis Ibrahim; Ian P Sinha; Nimish V Subhedar
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

2.  Hydrocortisone for refractory hypotension of very low birth weight infant with patent ductus arteriosus: a case report.

Authors:  Hyun Young Lee; Sang Hun Kim; Ki Tae Jung; Keum Young So
Journal:  J Anesth       Date:  2011-10-20       Impact factor: 2.078

Review 3.  Which inotrope for which baby?

Authors:  N Evans
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-05       Impact factor: 5.747

4.  Adding hydrocortisone as 1st line of inotropic treatment for hypotension in very low birth weight infants.

Authors:  Ori Hochwald; Gustavo Palegra; Horacio Osiovich
Journal:  Indian J Pediatr       Date:  2013-08-01       Impact factor: 1.967

5.  An evaluation of hydrocortisone dosing for neonatal refractory hypotension.

Authors:  E S Peeples
Journal:  J Perinatol       Date:  2017-05-18       Impact factor: 2.521

Review 6.  Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.

Authors:  David Kaufman; Karen D Fairchild
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

7.  Pathogenesis of neonatal necrotizing enterocolitis: a study of the role of intraluminal pressure, age and bacterial concentration.

Authors:  K L Chan; S P Ng; K W Chan; Y H Wo; P K H Tam
Journal:  Pediatr Surg Int       Date:  2003-10-09       Impact factor: 1.827

8.  Do cortisol concentrations predict short-term outcomes in extremely low birth weight infants?

Authors:  Susan W Aucott; Kristi L Watterberg; Michele L Shaffer; Pamela K Donohue
Journal:  Pediatrics       Date:  2008-10       Impact factor: 7.124

9.  Clinical characterization and long-term prognosis of neurological development in preterm infants with late-onset circulatory collapse.

Authors:  H Nakanishi; S Yamanaka; T Koriyama; N Shishida; N Miyagi; T-J Kim; S Kusuda
Journal:  J Perinatol       Date:  2010-04-01       Impact factor: 2.521

Review 10.  ROP surgery and ocular circulation.

Authors:  W A J van Heuven; J W Kiel
Journal:  Eye (Lond)       Date:  2008-03-21       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.